Now showing items 1-3 of 3
Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement
(COMENIUS UNIV, 2020)
The aim of this study is to evaluate the therapeutic effect of mesenchymal stem cells (MSCs) in a severe case of brain and multiple organ involvement in a patient with COVID-19. Here, a 51-year-old male patient with ...
The systematic effect of mesenchymal stem cell therapy in critical COVID-19 patients: a prospective double controlled trial
(Sage Journals, 2021)
The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the ...
Mesenchymal stem cell therapy in COVID-19 pneumonia: a prospective, randomized clinical research
(Turkiye Klinikleri, 2022)
Objective: Deficiencies in immune-regulatory mechanisms such as immune activation and T-regulatory cells are classically referred to as cytokine storms. Mesenchymal stem cells (MSCs) act as living anti-inflammatory cells ...